Homepage Featured (top) News
New research from The George Institute for Global Health questions the notion that a capped budget for new medicines is a good policy choice for Australia, as recommended for the Pharmaceutical Benefits Scheme (PBS) in the recent Commission of Audit.
Homepage Featured News (next 2)
Australian research published in The Lancet shows that more than two million people globally die unnecessarily every year because they cannot access treatment for kidney failure (dialysis or a kidney transplant). By 2030 the number of people receiving treatment is predicted to double to over five million.
Profiles and achievements
Sarah Coggan has been working at the George Institute since 2012 on a number of academic collaborations. She has experience in clinical trials as well as non-interventional health systems research in Chronic Kidney Disease and Diabetes. At TGI, Sarah facilitates qualitative and quantitative research studies, including randomised clinical trials, data linkage based projects and a needs-based analysis of current health-care models.